Author(s):
Ahmed Salim Mahmood, Ali Ismail Al-Gareeb, Faiq Isho Gorial
Email(s):
ahmedsalimmahmood@gmail.com
DOI:
10.52711/0974-360X.2021.00896 
Address:
Ahmed Salim Mahmood1*, Ali Ismail Al-Gareeb2, Faiq Isho Gorial3
1Department of Pharmacy, Al-Esraa University, Baghdad, Iraq.
2Department of Pharmacology, College of Medicine, AL-Mustansiriya University, Baghdad, Iraq.
3Department of Medicine, College of Medicine, University of Baghdad, Baghdad, Iraq.
*Corresponding Author
Published In:
Volume - 14,
Issue - 10,
Year - 2021
ABSTRACT:
Soluble adhesion molecules (mainly VCAM-1 and E-selectin) have a vital role in the pathogenesis of the rheumatoid arthritis (RA) and consider as angiogenic mediators for this disease. The main goal for this research is to evaluate the efficacy of orally administer niclosamide (NCS) in prevention the angiogenic mediators (VCAM-1 and E-selectin) using collagen induced arthritis model in rats (CIA). Fifty male Spraque-Dawley rats underwent collagen induced arthritis (CIA) model. When arthritis was fully developed, the rats were either treated orally with low-dose (50mg/kg) NCS or high-dose (100mg/kg) NCS or treated intrapertonially (IP) with 30mg/kg NCS or leave without treatment for 4 weeks. Body weight measurement and arthritis index were monitor before and after treatment in all groups. At the end of the treatment period serum level of vascular cell adhesion molecule-1 (VCAM-1), E-selectin and TNFa were measured together with collection of articular synovial tissue to evaluate the pathological changes. The experiment showed that NCS significantly reduce the arthritis index, foot pad thickness and ankle swelling (p value < 0.05) when given orally in a high dose and IP to the experimental animal. Comparing to the CIA model group, significant reduction in the serum level of VCAM1 and E-selectin has been observed in those rats treated with high dose of oral NCS or IP injection of NCS (p value < 0.05). Niclosamide can effectively decrease, in dose dependent manner, the clinical scores, joint swelling, VCAM1, E-selectin and pathological changes in arthritic rats induced by collagen type II.
Cite this article:
Ahmed Salim Mahmood, Ali Ismail Al-Gareeb, Faiq Isho Gorial. Effect of Orally-administration Niclosamide on serum level of VCAM-1 and E-selectin in Collagen induced arthritis: Experimental study. Research Journal of Pharmacy and Technology. 2021; 14(10):5150-6. doi: 10.52711/0974-360X.2021.00896
Cite(Electronic):
Ahmed Salim Mahmood, Ali Ismail Al-Gareeb, Faiq Isho Gorial. Effect of Orally-administration Niclosamide on serum level of VCAM-1 and E-selectin in Collagen induced arthritis: Experimental study. Research Journal of Pharmacy and Technology. 2021; 14(10):5150-6. doi: 10.52711/0974-360X.2021.00896 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-10-14
REFERENCES:
1. Suneel A, Venkatarathanamma. V, Naga V et al. Anti-arthritic Activity of Annona squamosa Leaves Methanolic Extract on Adjuvant Induced Arthritis in Rats. Res. J. Pharmacology and Pharmacodynamics. 2017; 9(2): 46-56.
2. Tanaji D, Priyajit H, Anuja K. Clinical Features and Treatment of Rheumatoid Arthritis: A Review. Research Journal of Pharmacy and Technology 11(12): 5701-5706
3. Spandana K, Varun C, Shivani M. Rheumatoid arthritis. Res. J. Pharma. Dosage Forms and Tech. 2019; 11(2): 131-133.
4. Iain BM, Georg Schett. The Pathogenesis of Rheumatoid Arthritis. N Engl J Med. 2011; 365(23): 2205-2219.
5. Szekanecz Z, Pakozdi A, Szentpetery A, et al.. Chemokines and angiogenesis in rheumatoid arthritis. Front Biosci (Elite Ed).,1: 44- 51. 2009.
6. Polzer K, Baeten D, Soleiman A, et al. Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints. Ann Rheum Dis. 2008; 67: 1610-1616.
7. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature. 1995; 376: 517-519.
8. Klimiuk P, Sierakowski S, Fiedorczyk M, Chwiecko J. AB0604 Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) in patients with early rheumatoid arthritis. Annals of the Rheumatic Diseases. 2013; 71: 673.
9. Wang L., Ding Y., Guo X., Zhao Q. Role and mechanism of vascular cell adhesion molecule-1 in the development of rheumatoid arthritis. Exp. Ther. Med. 2015; 10: 1229-1233.
10. Salmi AR, Farida I, Ahmad S et al. A study on Leflunomide- induced liver injury in Rheumatoid Arthritis Patients. Research J. Pharm. and Tech. 2013; 6(5): 556-561.
11. SK Firdoz, T Kumar, P Jyothi et al: Sulphasalazine Induced Hepatotoxicity, A Risk factor of Meconium Aspiration Syndrome in neonates: A Case Study. Research J. Pharm. and Tech. 2019; 12(3): 1201-1205.
12. Huang M, Qiu Q, Zeng S, Xiao Y, Shi M et al. Niclosamide inhibits the inflammatory and angiogenic activation of human umbilical vein endothelial cells. Inflamm. Res. 2015; 64: 1023.
13. Liang, L., Huang, M., Xiao, Y., Zen, S., Lao, M., Zou, Y., Shi, M., Yang, X., and Xu, H. Inhibitory effects of niclosamide on inflammation and migration of fibroblast-like synoviocytes from patients with rheumatoid arthritis. Inflammation Research. 2015; 64, 225-233.
14. Venkataramanan V, M Sumithra. A complete review on Rheumatoid arthritis and Diabetes Mellitus – A Unknown Connection. Research J. Pharm. and Tech 2018; 11(11): 5212- 5218.
15. JT Z. Modern Pharmacology Experiment Methods. Edition. Beijing: Beijing Medical College and Beijing Union Medical College Joint Publishing House. 1998.
16. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016; 388(10055): 2023-2038.
17. Mcnnes IB, Schett G. The pathogenesis of Rheumatoid Arthritis. N Engl J Med. 2011; 365: 2205-2219.
18. Tokuhira M,Hosaka S,Volin MV, Haines GK3rd,KatschkeKJJr, Kim S et al. Soluble vascular cell adhesion molecule 1 mediation of monocyte chemotaxis in rheumatoid arthritis. Arthritis Rheum. 2000; 43: 1122-1133.
19. Cerutti C., Ridley A.J. Endothelial cell-cell adhesion and signaling. Exp. Cell Res. 2017; 358: 31-38.
20. Mojcik CFand Shevach EM. Adhesion molecules, a rheumatologic perspective. Arthritis and Rheumatism. 1997; 40(6): 991-1004.
21. Haraoui B, Bykerk V. Etanercept in the treatment of rheumatoid arthritis. Therapeutics and Clinical Risk Management. 2007; 3(1): 99-105.
22. Kong DH, Kim YK, Kim MR, Jang JH, Lee S. Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer. Int J Mol Sci. 2018; 19(14): 1057.
23. M. Huang, S. Zeng, Q. Qiu, Y. Xiao, M. Shi, Y. Zou, et al. Niclosamide induces apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes. Int Immunopharmacol. 2016; 31: 45- 49.
24. Koch AE, Turkiewicz W, Harlow LA, Pope RM. Soluble E- selectin in arthritis. Clin Immunol Immmunopathol. 1993; 69(1): 29-35.
25. Tak PP, Taylor PC, Breedveld FC, Smeets TJM, Daha MR, Kluin PM, Meinders AE, Maini RN: Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor a monoclonal antibody treatment in patients with rheumatoid arthritis. Arthritis Rheum. 1996; 39: 1077-1081.
26. Kubes P, Jutila M, Payne D. Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion. J Clin Invest. 1995; 95: 2510- 2519.
27. Jakubowski A, Rosa MD, Bder S, Lobb R, Burkly LC. Vascular cell adhesion molecule (VCAM)-Ig fusion protein defines distinct affinity states of the very late antigen-4 (VLA-4) receptor. Cell Adhes Commun.. 1995; 3: 131-142.
28. Al-Gareeb AI, Aljubory KD, Alkuraishy HM. Niclosamide as an anti-obesity drug: An experimental study. Eat Weight Disord. 2017; 22: 339-344.
29. Pandi V, Vara P, P. Shanmugasundaram. A Prospective Study on Comparing the efficacy of Combination Therapy and Monotherapy of DMARDs in Patients with Rheumatoid Arthritis. Research J. Pharm. and Tech 2018; 11(10): 4497-4501.
30. B. Premkuma. Antioxidant Defense and Disease activity in Rheumatoid Arthritis. Research J. Pharm. and Tech 2018; 11(5): 1810-1814.
31. G. B. Jadhav, A. C. Deshmukh, K. N. Mundlod. Effect of Linagliptin and Niclosamide on Streptozotocin Induced Diabetic Neuropathy in Rats. Research J. Pharm. and Tech 2020; 13(5): 2101-2106.